The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 62 | — | 20.1x | Near average | |
Growth | 0 | — | 5.6% | Below average | |
Quality | 51 | 338.4% | 7.6% | Near average | |
Safety | 41 | 1.0x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | 82 | — | — | Above average | |
Sentiment | 62 | — | — | Near average |
Unicycive Therapeutics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Unicycive Therapeutics, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
UNCY stock shows a state of absolute consensus among analysts, with the price target stabilizing at $22 without any change over the past thirty days, reflecting a significant price gap (Upside) compared to the current price of $7.2. Notably, there is a complete lack of dispersion among the six analysts, as the minimum and maximum targets are equal, which is an indicator of strong shared conviction regarding the stock's fair value despite its nature as an early-stage growth project.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.